PRNP and colorectal carcinoma: The core aim of this research was to determine the potential of PRNP(PrPC) being utilized as a biomarker for predicting the prognosis and the treatment response to immune checkpoint inhibitors, while also elucidating its involvement in CRC’s EMT process.